P/E ratio for Aethlon Medical (AEMD)
P/E ratio as of May 2024 (TTM): -0.2927
According to Aethlon Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.292683. At the end of 2022 the company had a P/E ratio of -0.0544.
P/E ratio history for Aethlon Medical from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0544 | -86.41% |
| 2021 | -0.4000 | -15.95% |
| 2020 | -0.4759 | 1551.22% |
| 2019 | -0.0288 | -95.57% |
| 2018 | -0.6500 | 160.01% |
| 2017 | -0.2500 | -56.19% |
| 2016 | -0.5707 | -57.14% |
| 2015 | -1.33 | 39.45% |
| 2014 | -0.9547 | 89.39% |
| 2013 | -0.5041 | 58.6% |
| 2012 | -0.3179 | 128.86% |
| 2011 | -0.1389 | -19.31% |
| 2010 | -0.1721 | -64.43% |
| 2009 | -0.4839 | 168.33% |
| 2008 | -0.1803 | -72.35% |
| 2007 | -0.6522 | 54.59% |
| 2006 | -0.4219 | 58.52% |
| 2005 | -0.2661 | -38.26% |
| 2004 | -0.4310 | 47.58% |
| 2003 | -0.2921 | 76.71% |
| 2002 | -0.1653 | -49.05% |
| 2001 | -0.3244 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 PerkinElmer
PKI | 15.0 | -5,213.59% | 🇺🇸 USA |
 Pacific Biosciences
PACB | -1.33 | 354.66% | 🇺🇸 USA |
 Coherent
COHR | -18.5 | 6,236.58% | 🇺🇸 USA |
 Bruker BRKR | 36.4 | -12,543.29% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | -0.1188 | -59.39% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | -17.8 | 5,992.19% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.